Company Overview

Update
Headquarters:
Erkrath
Funding:
$5.50M
Categories:
Biotechnology

Algiax Pharmaceuticals develops products for nervous system disease or dysfunction with a strong focus on neuropathic pain.

Description

Update

Algiax Pharmaceuticals GmbH is an independent biotechnology company that was established in April 2011. It is dedicated to the discovery and development of innovative products in the field of nervous system disease or dysfunction with a strong focus on neuropathic pain. The company is financially stable having raised 4,3 million Euro’s in Series A financing from a consortium of private and state-backed investors.

Funding Rounds (1) - $5.50M

Update

Investors (2)

Update
  • 2c2b624e7df88771174f98e15d4c4370

    High-Tech Gruenderfonds

    German venture capital firm
  • 6f4ef4826a9e049e06ab2facd0d69c93

    KFW

    KfW Bankengruppe gives impetus to economic, social and ecological development worldwide. As a..

Offices/Locations (1)

Update
  • Office

    Max-Planck-Str. 15a

    Erkrath, 40699

    DEU